Would you start octreotide in a patient with suspected sulfonyurea overdose but without frank hypoglycemia?  

The data in the literature supports treating with Octreotide once hypoglycemia is present. Otherwise, a watchful, waiting period would be employed. It is reasonable to have a low threshold for its use once indicated, given how prolonged and profound the hypoglycemia can be in this situation.